Wednesday, June 1, 2016

BRIEF-Xtl Biopharmaceuticals Q1 loss per share $0.002

* XTL Biopharmaceuticals reports first quarter 2016

financial results & provides clinical and operational update

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)